Hong Kong Construction Stock News

Bitfire Group Holdings (SEHK:1611) has released its H1 2026 scorecard, with investors focused on how the latest numbers compare with a recent track record that includes trailing 12 month revenue of HK$7.2b and a loss of HK$241.8m, alongside basic EPS of HK$0.0051 in H2 2025 and a HK$0.0264 loss in H1 2025. Over the past few reported halves, the company has seen revenue move from HK$913.8m in H2 2024 to HK$3.5b in H1 2025 and HK$5.2b in H2 2025. Over the same period, basic EPS shifted from a...

In May 2026, Semiconductor Manufacturing International Corporation issued second-quarter guidance indicating that revenue is expected to rise 14% to 16% sequentially, signaling a stronger near-term operating outlook. This guidance suggests improving demand across its manufacturing lines and higher fab utilization, providing fresh context for how its expansion and localization efforts may be translating into top-line momentum. We’ll now examine how this anticipated double-digit sequential...

New World Development (SEHK:17) has drawn attention after a period of mixed share performance, with the stock down 3% over the past week and about 21% over the past 3 months. See our latest analysis for New World Development. Zooming out, the share price has fallen 21.3% over the past 90 days despite an 11.6% year to date share price return and an 81.3% total shareholder return over the past year. This suggests earlier momentum has faded recently as investors reassess risk and recovery...

Recent performance context for JD Logistics JD Logistics (SEHK:2618) has drawn attention after a recent pullback, with the stock down 12% over the past month, up about 20% in the past 3 months, and up 9% over the past year. See our latest analysis for JD Logistics. At a share price of HK$13.32, JD Logistics has seen short term momentum cool, with the 1 month share price return down 11.73%, even though the 1 year total shareholder return is 9.36%. This suggests longer term holders have fared...

Inspur Digital Enterprise Technology Limited ( HKG:596 ), might not be a large cap stock, but it saw a significant...

While China Gas Holdings Limited ( HKG:384 ) might not have the largest market cap around , it saw significant share...

It looks like Zhongmiao Holdings (Qingdao) Co., Ltd. ( HKG:1471 ) is about to go ex-dividend in the next four days. The...

While ITC Properties Group Limited ( HKG:199 ) shareholders have had a good week with the stock up 19%, they shouldn't...

Some investors rely on dividends for growing their wealth, and if you're one of those dividend sleuths, you might be...

It looks like Hebei Yichen Industrial Group Corporation Limited ( HKG:1596 ) is about to go ex-dividend in the next 4...

As global markets navigate a landscape marked by inflation concerns and geopolitical tensions, the Asian market remains a focal point for investors seeking growth opportunities. Penny stocks, often representing smaller or newer companies, continue to intrigue those looking for potential value beyond mainstream investments. Despite their vintage name, these stocks can offer surprising resilience and stability when backed by strong financials. This article explores three such penny stocks in...

CSPC Pharmaceutical Group Limited ( HKG:1093 ) shareholders will have a reason to smile today, with the analysts making...

Xiaomi (SEHK:1810) has just wrapped up FY 2025 with fourth quarter revenue of CN¥116.9b and basic EPS of CN¥0.25, capping a year in which trailing twelve month revenue reached CN¥457.3b and EPS stood at CN¥1.62 alongside year on year earnings growth of 76%. Over recent periods the company has seen quarterly revenue move from CN¥92.5b in Q3 2024 to CN¥109.0b in Q4 2024 and then into the CN¥111.3b to CN¥116.9b range through FY 2025. Over the same time, trailing net profit margin has shifted...

Oriental Explorer Holdings Limited ( HKG:430 ) stock is about to trade ex-dividend in four days. Typically, the...

Hansoh Pharmaceutical Group (SEHK:3692) has drawn fresh investor attention after announcing that its self developed Class 1 drug candidate HS-10541 received clinical trial approval in China for KRAS G12C mutated advanced solid tumors. See our latest analysis for Hansoh Pharmaceutical Group. The HS-10541 trial approval comes as Hansoh Pharmaceutical Group's share price has softened recently, with a 30 day share price return down 13.62%, even while the 1 year total shareholder return stands at...

As the Asian markets navigate a complex landscape of geopolitical tensions and economic uncertainties, investors are increasingly focused on companies with strong growth potential and significant insider ownership. In this environment, stocks that combine robust internal backing with promising expansion prospects can offer a compelling investment narrative.

As global markets navigate a complex landscape marked by inflation concerns and geopolitical tensions, the Asian market remains a focal point for investors seeking opportunities in emerging sectors. Penny stocks, though an older term, continue to represent smaller or less-established companies that can offer significant value and growth potential. By focusing on those with robust financials and clear growth trajectories, investors might uncover promising opportunities among these lesser-known...

Electric vehicle demand and technical rebound thesis Recent analyst commentary on Aluminum Corporation of China (SEHK:2600) discusses a potential technical rebound, connecting current interest in the stock to aluminum demand associated with the expanding electric vehicle industry. See our latest analysis for Aluminum Corporation of China. At the latest share price of HK$11.88, the stock has seen a sharp 1-day share price return of 9.29% and 7-day share price return of 14.56%, even though the...

Amidst a backdrop of rising inflation worries and fluctuating consumer sentiment, global markets have shown resilience, with major U.S. stock indexes reaching new highs and small-cap stocks outperforming their larger peers. In such a dynamic market landscape, investors often look beyond the well-trodden paths to discover potential in lesser-known areas like penny stocks. While the term "penny stocks" might seem outdated, these smaller or newer companies can offer unique growth opportunities...

CSPC Pharmaceutical Group (SEHK:1093) has recently secured Chinese approvals for Enyike, a ustekinumab biosimilar, and 4mg budesonide enteric-coated capsules, broadening its autoimmune and nephrology treatment offerings for patients. See our latest analysis for CSPC Pharmaceutical Group. At a latest share price of HK$7.69, the stock has seen a 1-day share price return of 4.77% and a 7-day share price return of 1.45%, but a 90-day share price return that is down 23.56%. The 1-year total...

Investors who take an interest in China Qinfa Group Limited ( HKG:866 ) should definitely note that the CEO, President...

Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...

HBM Holdings (SEHK:2142) is in focus after Harbour BioMed reported preclinical data for LET003, an ACVR2A/2B-targeting antibody developed using its AI-based Hu-mAtrIx platform, showing superior pharmacokinetics compared with several competitors. See our latest analysis for HBM Holdings. At a share price of HK$12.15, HBM Holdings has seen the 30 day share price return fall 13.21%, even as the 1 year total shareholder return is 37.91% and the 3 year total shareholder return is very large. This...

Amid a backdrop of rising inflation concerns and geopolitical tensions, major U.S. stock indexes have reached new heights, driven by enthusiasm around artificial intelligence stocks and positive earnings reports. As the market landscape continues to evolve, investors might find opportunities in areas often overlooked by mainstream attention. Penny stocks, though sometimes seen as relics of past speculative trends, remain relevant for those seeking growth potential in smaller or newer...